INTRODUCTION
Lower limb peripheral arterial disease (PAD) and, in particular, critical limb ischaemia (CLI) markedly increase the risk of both debilitating limb loss and adverse cardiovascular events. Today, an estimated 200 million people worldwide are affected by PAD, with the number constantly increasing, owing not only to longer life expectancy, but also to manifestation of the disease at a younger age. 1e3 Early detection of PAD and initiation of optimal medical and conservative treatment is thus becoming increasingly important.
Measurements of ankle and toe systolic pressures (AP and TP, respectively) and their relation to that in the arm (ankle brachial index [ABI] and toe brachial index [TBI] ) have been widely applied to the initial assessment of peripheral circulation. The diagnostic limitations of ABI have been thoroughly addressed. Decreased ABI (< 0.9) has been shown to be strongly associated with increased risk of myocardial infarction and cardiovascular death. 4, 5 However, the usefulness of ABI may be reduced in conditions such as diabetes, chronic kidney disease, and advanced age, owing to arterial stiffening and incompressibility of the leg arteries at ankle level.
6e8 Both low and high ABI among diabetic patients correlate with increased risk of cardiovascular mortality in a U-shaped fashion. 8, 9 Thus, arterial stiffening may reduce both the diagnostic and prognostic value of ABI, especially among diabetics.
As digital arteries are generally regarded as less susceptible to vessel stiffness, the use of TP and TBI has been recommended in order to overcome the influence of arterial incompressibility. 6, 9 However, among diabetics the diagnostic value of TBI has been questioned. 10, 11 The correlation of low TP with increased mortality and decreased amputation free survival (AFS) has been demonstrated in patients with incompressible leg arteries. 12, 13 In addition to AP and ABI, TP is used in the widely accepted TransAtlantic Inter-Society Consensus II (TASC II) classification of limb ischaemia.
14e17 Low TP appears to serve as a prognostic marker for wound healing in PAD. 14 Further risk stratification of patients with CLI based on the severity of tissue loss, ischaemia, and foot infection (WIfI) has recently been created by the Society for Vascular Surgery Lower Extremity Guidelines Committee. 18 Yet, not every patient with haemodynamic criteria for severe ischaemia, even according to WIfI, may require revascularisation. 13 Even today, data regarding means of identifying which patients with PAD have the greatest risk of major cardiovascular events or amputation is limited. Non-invasive measurement of haemodynamic parameters is feasible and routinely carried out in vascular practice. However, the overall relative prognostic value of AP, ABI, TP, and TBI remains to be further elucidated. We have analysed the relationship between these parameters and mid-term cardiovascular and all-cause mortality, as well as AFS in vascular surgical patients. To the authors' knowledge, there are few previous data comparing all four parameters in a setting that encompasses all symptomatic patients with PAD.
METHODS

Study cohort
This retrospective study consisted of all consecutive symptomatic patients with PAD admitted to the Department of Vascular Surgery, Turku University Hospital, Turku, Finland, for either diagnostic or therapeutic conventional lower limb angiography (digital subtraction angiography [DSA]) from 1 June 2009 to 31 August 2011. The aim was to analyse the influence of peripheral pressures and pressure indices on 36 month survival at the time of clinical presentation with insufficient arterial circulation, before any revascularisation procedures. Although 887 patients were recruited, standardised peripheral pressure measurements were available for only 732 patients. This is a result of poor availability of vascular laboratory measurements outside office hours. Patients were included irrespective of their earlier PAD history. The study protocol was approved by the local ethical committee of the Hospital District of South-West Finland. Owing to the retrospective nature of this study, informed patient consent was not required.
Vascular laboratory
Standardised non-invasive haemodynamic measurements were carried out by experienced vascular technicians at Turku University Hospital Vascular Laboratory. Measurements were obtained with patients in a supine position with feet at heart level, using a Nicolet VasoGuard (Nicolet Vascular Inc. Madison, WI, USA) photoplethysmography (PPG) device in all patients. When stable signals were obtained, brachial, ankle, and digital cuffs were inflated until disappearance of the PPG signal, typically up to 200 mmHg. Brachial pressure, AP, and TP were determined by gradual deflation of the cuffs to the moment of reappearance of a pulsatile signal. Signals were later checked offline. TP was preferentially measured from the great toe or, if it was missing, from the nearest available toe. A mean of 3e5 measurements of TP was used for analysis. Either APs or TPs were available for 732 patients prior to possible revascularisation. AP and ABI were available for 720 patients, and TP and TBI for 717 patients. In 708 patients both measurements were available. Measurements for the clinically relevant limb were registered. When both limbs were symptomatic, measurements for the limb with the lowest TP were registered. Where TP was not available, measurements for the limb with the lowest AP were registered.
TP and TBI were not measurable in 15 patients with previous forefoot amputations or severe tissue loss involving the toes. AP was unavailable for 12 patients, either owing to pain or reduced ability to cooperate. Pressure indices for one patient were not available owing to apparently incompressible arteries in both upper extremities with bilateral non-occluded cuff pressures of > 250 mmHg in the arms.
Data collection
Patient baseline characteristics at admission, which served as the index date for follow-up, were retrospectively collected from the hospital electronic database. Only International Classification of Diseases (ICD) 10 coded diagnoses were registered. The following risk factors were collected for analysis: coronary artery disease (CAD), cerebrovascular disease (CVD), hypertension, active smoking, diabetes, sleep apnea, chronic obstructive pulmonary disease (COPD), end stage renal disease (ESRD), dyslipidemia, AP, ABI, TP, TBI, and serum creatinine level. Baseline medication including statins, clopidogrel, aspirin, warfarin, and novel anticoagulants was registered from within electronic patient files where reliably available. A reliable medication history was unavailable for 51 patients (7.0%). Deaths within the patient cohort were registered for the first 36 months, which was the cutoff point for follow-up. Later, in 2015, the causes of death were collected from the Finnish centre for statistics, which has a 2 year delay in publishing official mortality data. For the purposes of this study, causes of death were categorized into cardiovascular and other. Only major (above-ankle) amputations were registered.
For statistical analysis, peripheral pressures were pooled into categories adapted from the TASC II recommendation. 16 Categories for ankle pressures were < 50 mmHg, 50e 69 mmHg, and ! 70 mmHg, and indisputably incompressible leg arteries with a pressure of > 250 mmHg were assigned to category 4. TP data were pooled into three categories: 0e 
Statistical analyses
All statistical analyses were performed using SPSS version 22 (IBM, Armonk, NY, USA). Group specific baseline characteristics are presented as percentages, and continuous variables as mean AE SD. Group variables were compared using Pearson's chi-square test. For continuous variables a ShapiroeWilk test was run to test the normality of the variables. Variables were then compared by analysis of variance, as the continuous variables in each group were normally distributed.
KaplaneMeier survival curves representing cumulative survival were constructed for the study groups based on haemodynamic measurements as described above. Survival curves for each variable in defined groups were compared using Wilcoxon statistics. For Cox regression analysis, a univariate analysis using the Cox model was first performed, then the variables with a p value < .15 in the univariate analysis were added to the model. All study outcomesdcardiovascular and overall mortality and AFdwere analysed separately. For multivariate Cox regression analysis, haemodynamic measures resulting in p values < .15 on all outcomes, cardiovascular, and overall mortality and AFS were included. The highest group was selected as reference for categorical pressures and indices. To avoid false positive observations the p values were Bonferroni adjusted if they include multiple exposures. A p value < .05 was considered statistically significant. 
RESULTS
Patient characteristics, pressure indices, and peripheral pressure categories
Forty-two percent of the study population were women and the mean age was 72 AE 11 years. General patient characteristics are presented in Table 1 . Category specific patient characteristics are shown in Table S1 for AP and Table S2 for TP (see Supplementary Material) (see Table 2 ).
TP and patient outcome
The cardiovascular survival within TP groups was as follows: 
AP and patient outcome
The cardiovascular survival within AP groups was as follows: (i) AP < 50 mmHg: 28.7 months (SE 1.5; 95% CI 25.8e31.7);
(ii) TP 50e69 mmHg: 32.6 months (SE 0.81; 95% CI 31.0e 34.2); (iii) TP ! 70e250 mmHg: 33.4 months (SE 0.45; 95% CI 32.5e34.3); and (iv) > 250 mmHg 30.2 months (SE 1.6; 95% CI 27.0e33.3). Patients with AP ! 70 mmHg had significantly less cardiovascular mortality than those with an AP < 50 mmHg (p < .001) or incompressible leg arteries with an AP > 250 mmHg (p < .015) (Fig. 1B) . Corresponding KaplaneMeier curves for OS and AFS are presented in Figs  2(B) and 3(B) , respectively.
TBI and patient outcome
Cardiovascular survival within the TBI groups was as follows: (i) TBI < 0.25: 30.3 months (SE 0.71; 95% CI 28.9e 31.7); (ii) TBI 0.25e0.49: 33.5 months (SE 0.52; 95% CI 32.5e34.6); and (iii) TBI ! 0.50: 35.9 months (SE 0.52; 95% CI 34.9e36.9). Cardiovascular mortality in the group with a TBI < 0.25 was significantly increased compared with other groups (TBI 0.25e0.49: p < .001; TBI ! 0.50: p < .001 [ Fig. 1C] ). KaplaneMeier curves for OS and AFS are presented in Figs 2(C) and 3(C), respectively.
ABI and patient outcome
Cardiovascular survival within the ABI groups was as follows: (i) ABI < 0.25: 27.5 months (SE 1.9; 95% CI 23.7e 31.2); (ii) ABI 0.25e0.49: 32.9 months (SE 0.70; 95% CI 
Cox regression analysis
For the multivariate Cox regression analysis, risk factors were selected according to the Cox univariate analysis. For all three outcomes, age, CAD, CVD, hypertension, diabetes, ESRD, dyslipidemia, and smoking history were added to the model based on p < .15. For analysis of cardiovascular mortality, COPD was also added to the model owing to p < .15.
Including TP in multivariate analysis showed that for all study endpoints (cardiovascular and overall mortality and amputation or death) TP < 30 mmHg (vs. TP ! 50 mmHg) was associated with a significant risk (hazards ratio [ Table 3 ). For all selected risk factors and study endpoints, and results of the Cox models see Tables S2eS4 (Supplementary Material) .
Multivariate analysis, including TBI, showed that for all three study endpoints (cardiovascular and overall mortality and amputation or death) TBI < 0. 25 Table 4 ). For all selected risk factors and study endpoints, and the results of the Cox models see Tables S2eS4 (Supplementary  Material) .
Multivariate analysis did not show any significant risk associations for the AP and ABI groups. For all risk factors and study endpoints, and results of the Cox models, see Tables S2eS4 (Supplementary Material) .
DISCUSSION
The association of an ABI < 0.9 with an increased rate of cardiovascular events and overall mortality has been known for decades. 20, 21 The relationship is U-shaped owing to incompressible leg arteries affecting the values, especially among diabetics. 8, 9 In a series of patients with PAD, with and without diabetes, an ABI > 1.3 increased amputation rates in both groups in a similar fashion. 22 Studies on the association between TP and patient outcome are scarce. A few studies have demonstrated the predictive effect of TBI on cardiovascular mortality and morbidity, irrespective of the diabetic status of the patient. 9, 23 In this study, which included > 700 patients with TP measurements, a linear correlation between TP and TBI with cardiovascular and overall mortality, as well as AFS, was shown. Furthermore, in line with earlier studies, a U-shaped correlation between ABI and all three investigated endpoints was observed. The data emphasise the pitfalls in relying solely on ABI when assessing patients with PAD and their prognosis. In the present study population 41% were diabetic and 10% had incompressible leg arteries with an ABI > 1.3. Moreover, it is conceivable that APs in some limbs may be falsely high owing to undetected partial vessel wall incompressibility.
The role of TBI in diagnosing PAD is indefinable, and criteria for stratifying normal versus pathological TBI remain ambiguous. Guidelines recommend < 0.70 as a cutoff, but this is not entirely evidence based. 24 There are no data confirming the utility of TBI in early detection of PAD among diabetics. In a recent Dutch study, which included patients with an ABI 1.4, diabetes appeared to falsify ABI and TBI in a similar fashion. 11 It may be worth noting that, in the present study, 7% of patients with a TBI ! 0.25 had a TP < 30 mmHg. Nonetheless, an increased cardiovascular mortality and poor OS in the group with a TBI < 0.25 was observed. Between the defined categories, the increased risk was step wise. This result is in line with a previous study by Hyun et al., 9 although their approach was different. A normal TBI value was a rarity in the present study, with the indices of only eight patients exceeding 0.75.
The risk of amputation has been demonstrated to be associated with low TP values.
25e27 According to the present data, TP has a strong association with mid-term cardiovascular and all-cause mortality, as well as AFS. All-cause mortality has previously been linked to low TP in a relatively small cohort of 53 patients and 76 limbs, with similar results to the data presented here. 26 The current study is an analysis of 732 patients. TP values fulfilling the criteria for CLI were observed in 233 patients (TP < 30 mmHg). The findings further support the notion that TP may serve as a powerful, non-invasive tool for detecting patients at highest risk of death and therefore being in need of optimal medical prevention of major cardiovascular events, death, or major amputation. The use of TP as a single prognostic or diagnostic tool for the evaluation of patients at risk of cardiovascular events is a tempting option, as it is a simple, noninvasive method available even in a general practitioner's office. 24 It may also provide a tool superior to ABI for screening high risk patients at diabetes outpatient clinics, owing to linear risk stratification.
In the present study, TP measurements were categorized according to criteria for CLI. 16, 17, 28 It is generally accepted that CLI is associated with poor patient outcome. 20, 29 According to the present data, a TP < 50 mmHg, and especially a TP < 30 mmHg, is significantly associated with poor patient outcome, further supporting the malignant nature of CLI.
Poor exercise capacity has been suggested to be the strongest predictor of mortality among patients with PAD, even compared with all earlier known major risk factors for PAD and CAD. 30, 31 Non-invasive limb pressure measurements were not assessed by these analyses. The prognostic value of combined exercise capacity and distal non-invasive pressure measurements on mortality is a tempting target for further studies.
When considering generalisation of the present results, it should be kept in mind that all the patients had symptomatic PAD and were referred for DSA by a vascular specialist. Thus, the cohort did not include individuals who did not fulfill the criteria for invasive treatment and are preferentially taken care of by primary healthcare. However, the study population was wide and heterogeneous, as it contained patients irrespective of diabetic status or PAD history. Owing to this, the results obtained should be widely applicable to everyday vascular practice.
CONCLUSIONS
Earlier studies have also demonstrated a U-shaped prognostic value of ABI on patient survival. In addition, ABI has been shown to be a potent non-invasive tool in PAD screening. In many vascular units, AP, ABI, TP, and TBI are essential measurements for clinical decision making and are routinely analysed in everyday practice. There are no earlier studies comparing all four variables and patient outcome in a single study setting. Based on the present observations, it is suggested that non-invasive measurement of TP and TBI are predictive of cardiovascular mortality, overall mortality, and AFS in patients with PAD, in a linear fashion.
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